Showing 4,941 - 4,960 results of 9,864 for search '"drug"', query time: 0.11s Refine Results
  1. 4941

    Physiology-informed regularisation enables training of universal differential equation systems for biological applications. by Max de Rooij, Balázs Erdős, Natal A W van Riel, Shauna D O'Donovan

    Published 2025-01-01
    “…These models can aid in the discovery of disease mechanisms and potential drug targets. However, on one hand the development and validation of knowledge-based mechanistic models is time-consuming and does not scale well with increasing features in medical data. …”
    Get full text
    Article
  2. 4942

    Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib by Vineeth Sukrithan, Lisa Kim, Jennifer A. Sipos, Ashima Goyal, Ye Zhou, Daniel Addison, Manisha Shah, Bhavana Konda, Ajay Vallakati

    Published 2023-01-01
    “…However, in the phase III SELECT trial of the drug in thyroid cancer, 5.4% of patients on lenvatinib experienced arterial thromboembolic events, with 2.7% experiencing severe grade ≥3 toxicities associated with arterial vascular events. …”
    Get full text
    Article
  3. 4943

    Spatially controlled multicellular differentiation of stem cells using triple factor-releasing metal–organic framework-coated nanoline arrays by Yeon-Woo Cho, Min-Ji Kang, Joon-Ha Park, Yun-Sik Eom, Tae-Hyung Kim

    Published 2025-02-01
    “…Abstract Improved in vitro models are needed for regenerative therapy and drug screening. Here, we report on functionally aligned nanoparticle-trapped nanopattern arrays for spatially controlled, precise mesenchymal stem cell differentiation on a single substrate. …”
    Get full text
    Article
  4. 4944

    Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity by Kenji Tsuji, Shinji Kitamura, Jun Wada

    Published 2018-01-01
    “…Over the past few decades, many studies identified trophic factors from MSCs, which attenuate renal injury in a variety of animal acute kidney injury models, including renal ischemia-reperfusion injury and drug-induced renal injury, using microarray and proteomic analysis. …”
    Get full text
    Article
  5. 4945

    Baricitinib for the Management of SARS-CoV-2-Infected Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials by Sivananthan Manoharan, Lee Ying Ying

    Published 2022-01-01
    “…Therefore, it needs to be explored to further understand the clinical benefits of this drug in the management of COVID-19 patients. Does baricitinib statistically significantly reduce mortality and disease progression in COVID-19 patients? …”
    Get full text
    Article
  6. 4946

    Administrative Criminal Reform in Providing Accountability for Skincare Actors Who Have Not Registered with BPOM by Aulia Putri, Ifahda Pratama Hapsari

    Published 2024-12-01
    “…The study aimed to analyze which problem from skincare products none approval from Indonesian Food and Drug Administration  (BPOM) This is serious problem the affects public health and damages consumer trust. …”
    Get full text
    Article
  7. 4947

    Vibrio parahaemolyticus: Exploring its Incidence in Malaysia and the Potential of Streptomyces sp. as an Anti-Vibrio Agent by Ke-Yan Loo, Loh Teng-Hern Tan, Jodi Woan-Fei Law, Priyia Pusparajah, Sunny Hei Wong, Kok-Gan Chan, Learn-Han Lee, Vengadesh Letchumanan

    Published 2023-06-01
    “…., a class of filamentous, Gram-positive bacteria that produce a variety of bioactive compounds during their life cycle, which can be useful in drug discovery. The bioactive compounds produced by Streptomyces sp. have been proven to have microbiota-modulating and stimulatory effects on the host, enhancing immunity and providing protective effects against V. parahaemolyticus infections. …”
    Get full text
    Article
  8. 4948

    Use of Artemisinin- Combination Therapies in Port Harcourt by OA Shorinwa, OO Ebong

    Published 2013-07-01
    “…The respondents that took artemisinin based combination drugs were 230 (32.1%), those that took artesunate only were 174 (24.3%), those that took chloroquine were 101 (14.1%) while those that took sulphadoxine/pyrimethamine were 140 (19.5%) while 72 (10%) took other antimalarial drugs. …”
    Get full text
    Article
  9. 4949

    A Pharmacotherapy and ECT resistant OCD patient’s Cognitive Behavioral Therapy by Tacettin KURU, M. Hakan TÜRKÇAPAR

    Published 2013-12-01
    “…Results: Cognitive Behavioral Therapy is an effective treatment for treatment-resistant patients with drug and ECT. [JCBPR 2013; 2(3.000): 173-181]…”
    Get full text
    Article
  10. 4950
  11. 4951

    Risky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes? by Toni Mora, Rowena Jacobs, Jordi Cid, David Roche

    Published 2025-02-01
    “…We test whether medication use for ADHD decreases the likelihood of risky behaviour (sexual behaviour, alcohol, tobacco, and drug consumption) and injuries amongst children aged 6–18. …”
    Get full text
    Article
  12. 4952

    In-Silico Evaluation of Binding Interaction and ADME Properties of Novel Pyrazoline and Pyrimidine Derivatives Targeting Cyclooxygenase-2 Enzyme by Sarmad Abbas Fadhil, Karima Fadhil Ali, Wesen Adel Mehde

    Published 2025-01-01
    “…Through in-silico methods, the binding affinity of these derivatives to the COX-2 receptor was predicted using computer simulations and compared with the reference drug, meloxicam. Docking studies employing gold software facilitated the visualization of ligand-protein interactions, utilizing the crystal structure of the COX-2 protein (PDB ID: 4m11). …”
    Get full text
    Article
  13. 4953

    Complete Whole-Genome Sequence of Streptomyces sp. MUM 178J, a Potential Anti-Vibrio Agent by Ke-Yan Loo, Loh Teng-Hern Tan, Kah-Ooi Chua, Priyia Pusparajah, Kok-Gan Chan, Learn-Han Lee, Jodi Woan-Fei Law, Vengadesh Letchumanan

    Published 2024-02-01
    “… Streptomyces sp. is a group of filamentous, Gram-positive bacteria notoriously known for their capabilities in producing bioactive compounds that have been used as novel drugs and lead in drug development. The Streptomyces sp. …”
    Get full text
    Article
  14. 4954

    Gambaran Tingkat Kepatuhan Pengobatan Pasien TB Paru by Endang Martini, Rika Sarfika, Siti Yuliharni

    Published 2024-10-01
    “… Adherence to tuberculosis (TB) treatment is crucial for achieving cure and preventing drug resistance. Low adherence can lead to treatment failure and increase the risk of infection transmission. …”
    Get full text
    Article
  15. 4955

    From Lab to Clinic: Effect of Academia–Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry by Wonseok Yang, Sang‐Won Lee

    Published 2025-01-01
    “…This study sheds light on how the characteristics of partnerships influence the success rates of early‐phase research, providing valuable insights for future strategic planning in oncology drug development.…”
    Get full text
    Article
  16. 4956

    Inflammation, impaired motor function and visceral hypersensitivity: the main mechanisms of functional disorders of the gastrointestinal tract (materials of the Expert Council and... by V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, A. A. Sheptulin, T. L. Lapina, V. I. Simanenkov, K. A. Sokolov

    Published 2022-05-01
    “…This often leads to the prescription of a complex of various medications to such patients, which increases the risk of undesirable drug interactions and side effects. Multitargeted therapy involves the use of drugs that simultaneously affect different pathogenetic links. …”
    Get full text
    Article
  17. 4957
  18. 4958

    Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review by Jawaher Ansari, Muhammad Ali, Ashraf Farrag, Arwa M. Ali, Abdulaziz Alhamad

    Published 2018-01-01
    “…In addition, there is uncertainty regarding drug dosing/pharmacokinetics, lack of safety and efficacy data, and potential for increased toxicity when using targeted therapy or immunotherapy for the management of patients with mRCC on dialysis. …”
    Get full text
    Article
  19. 4959

    Application of Synthetic Polymeric Scaffolds in Breast Cancer 3D Tissue Cultures and Animal Tumor Models by Girdhari Rijal, Chandra Bathula, Weimin Li

    Published 2017-01-01
    “…The scaffolding technology has appealing potentials to be applied in anticancer drug screening for a better control of the progression of human cancers.…”
    Get full text
    Article
  20. 4960

    New Insights into Aspirin’s Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites by George J. Kontoghiorghes

    Published 2024-12-01
    “…The mode of action of aspirin as a chelating antioxidant pro-drug of the ACMs, with continuous presence in LTLDA users, increases the prospect for prophylaxis in cancer and other diseases. …”
    Get full text
    Article